Trung Phuoc Nguyen

Dr. Trung Phuoc Nguyen

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2018 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
TNTrung Phuoc Nguyen
Trung Phuoc Nguyen
JSJeff Schaffert
Jeff Schaffert
CLChristian LoBue
Christian LoBue
KWKyle B. Womack
Kyle B. Womack
JHJohn Hart
John Hart
CCC. Munro Cullum
C. Munro Cullum
Background: Traumatic brain injury (TBI) with loss of consciousness (LOC) has been associated with earlier onset of mild cognitive impairment, frontotemporal dementia, Parkinson’s disease, and Alzheimer’s disease (AD), but has not been examined as a

5 June 2022 in Geriatrics
Verified
Journal Article
Open access
PDF file
HCHsueh-Sheng CHIANG
Hsueh-Sheng CHIANG
AKAlka Khera
Alka Khera
BSBarbara Stopschinski
Barbara Stopschinski
OSOlaf Stuve
Olaf Stuve
JHJohn Hart
John Hart
TNTrung Phuoc Nguyen
Trung Phuoc Nguyen
Several important questions regarding cognitive aging and dementia in older people with multiple sclerosis (PwMS) are the focus of this narrative review: Do older PwMS have worse cognitive decline compared to older people without MS? Can older PwMS develop dementia or other neurodegenerative diseases such as Alzheimer’s disease (AD) that may be accelerated due to MS? Are there any potential biomarkers that can help to determine the etiology of cognitive decline in older PwMS? What are the neural and cellular bases of cognitive aging and neurodegeneration in MS? Current evidence suggests that cognitive impairment in MS is distinguishable from that due to other neurodegenerative diseases, although older PwMS may present with accelerated cognitive decline. While dementia is prevalent in PwMS, there is currently no consensus on defining it. Cerebrospinal fluid and imaging biomarkers have the potential to identify disease processes linked to MS and other comorbidities—such as AD and vascular disease—in older PwMS, although more research is required. In conclusion, one should be aware that multiple underlying pathologies can coexist in older PwMS and cause cognitive decline. Future basic and clinical research will need to consider these complex factors to better understand the underlying pathophysiology, and to improve diagnostic accuracy.

1 August 2023 in Actuators
Verified
Journal Article
Open access
PDF file
ASAbhishek Pratap Singh
Abhishek Pratap Singh
DPDarshan Palani
Darshan Palani
OAOnan Ahmed
Onan Ahmed
PMPawandeep Singh Matharu
Pawandeep Singh Matharu
TLTristan Linn
Tristan Linn
Yonas TadesseYonas Tadesse
Yonas Tadesse
In this paper, a new socially assistive robot (SARs) called HBS-1.2 is presented, which uses 6-ply twisted and coiled polymer (TCP) artificial muscles in its hand to perform physical tasks. The utilization of 6-ply TCP artificial muscles in a humanoid robot hand is a pioneering advancement, offering cost effective, lightweight, and compact solution for SARs. The robot is designed to provide safer human–robot interaction (HRI) while performing physical tasks. The paper explains the procedures for fabrication and testing of the 6-ply TCP artificial muscles, along with improving the actuation response by using a Proportional-Integral-Derivative (PID) control method. Notably, the robot successfully performed a vision-based pick and place experiment, showing its potential for use in homecare and other settings to assist patients who suffer from neurological diseases like Alzheimer’s disease. The study also found an optimal light intensity range between 34 to 108 lumens/m2, which ensures minimal variation in calculated distance with 95% confidence intervals for robust performance from the vison system. The findings of this study have important implications for the development of affordable and accessible robotic systems to support elderly patients with dementia, and future research should focus on further improving the use of TCP actuators in robotics.

1 May 2025 in Cognitive and Behavioral Neurology
Verified
Journal Article
Closed access
JSJeff Schaffert
Jeff Schaffert
WGWilliam Goette
William Goette
TNTrung Phuoc Nguyen
Trung Phuoc Nguyen
AKAlka Khera
Alka Khera
RRRobert PsyD Ruchinskas
Robert PsyD Ruchinskas
Background: NeuroQuant volumetric data proposes to assist clinical diagnoses of mild cognitive impairment (MCI) and Alzheimer disease (AD) through normative hippocampal volume measurements (HVs) and hippocampal occupancy scores (HOCs). We investigated the diagnostic utility of NeuroQuant HVs and HOCs within an academic memory disorders clinic. Methods: Participants (n = 181) underwent neurologic examination, MRI with NeuroQuant, and neuropsychological assessment. Clinical diagnoses included subjective cognitive concerns (n = 39), non-amnestic MCI (n = 33), amnestic MCI (n = 74), AD (n = 35). Objective memory impairment (n = 125) was determined using actuarial criteria (≥2 memory measures ≤1.5 SD below the mean) for each participant. Differences in HVs and HOCs were assessed using ANOVA and χ2, while Pearson correlations examined their relationship with the California Verbal Learning Test-2nd Edition (CVLT-II). Receiver operator characteristic curves were used to calculate sensitivity, specificity, predictive values, Youden’s Index, and predictive summary index scores. Results: Participants with amnestic MCI, AD, and objective memory impairment had lower HVs and HOCs and a higher frequency of hippocampal atrophy (≤5th percentile) than participants with subjective cognitive concerns, non-amnestic MCI, and no objective memory impairment (P ’s <0.05). However, the sensitivity (0.31–0.77) and specificity (0.68–0.91) of HVs and HOCs were variable for determining objective memory impairment, and correlations with the CVLT-II were modest (r = 0.20–0.44). Discussion: NeuroQuant HVs and HOCs were lower in participants with amnestic MCI, AD, and memory impairment, but had poor sensitivity and specificity to predict memory impairment, and only a modest association with measurable memory impairment. These measures should be used cautiously as supporting diagnostic tools.